Solutions

Clinical Decision Support and Predictive Models

The category with the widest internal range. A reference subscription and an embedded risk model are both clinical decision support and they are governed nothing alike.

The short answer

Clinical decision support runs from curated reference content a clinician consults deliberately, through rules-based alerting, to predictive models that score risk unprompted. The first is a library decision. The last is a governance decision that brings validation, monitoring, bias review, and accountable ownership with it. Establishing which one you are buying determines the entire review route.

Explained at three levels

1 Plain English

Some of this is a very good reference book the doctor looks things up in. Some of it is the system warning you about a drug interaction. Some of it is software quietly deciding which patients look like they are getting worse. Those are wildly different things with the same label.

2 Informed buyer

The first practical step in this category is usually not evaluating a purchase. It is finding out what predictive capability is already switched on inside the electronic health record, because most health systems have some and many cannot immediately produce the list.

3 Technical and professional detail

A predictive model embedded in the record is subject to the same governance expectations as a purchased standalone model: intended use, validation population, monitoring plan, named owner, and inventory entry. The fact that it arrived as a feature rather than a purchase does not change the obligation, and it is the most common gap found when an organization first builds an AI model inventory.

The three shapes

Reference and knowledge content. Consulted deliberately by a clinician. Bought as a subscription, evaluated on coverage, currency, editorial process, and in-workflow accessibility. Governance load is light.

Rules-based alerting. Deterministic logic inside the record: interactions, allergies, dosing, care gaps. Evaluated on alert burden as much as on correctness, because an alerting layer that fires too often produces override behavior that degrades the whole system.

Predictive models. Score risk or likelihood without being asked. Evaluated as clinical AI: validation population, performance at local prevalence, subgroup behavior, monitoring, and accountable ownership.

Start with what you already have

The most common finding when a health system begins governing this category is that it already runs predictive models it had not catalogued, shipped inside the electronic health record or inside purchased clinical systems.

That is not negligence, it is how the software arrived. But it does mean the first question in this category is usually an inventory question rather than a purchasing one, and it frequently changes what the organization decides to buy.

Alert burden is the recurring failure

Decision support has a long, documented history of degrading through volume. Alerts that fire too frequently get dismissed reflexively, including the ones that mattered.

The practical implication for evaluation is that override rate belongs in the monitoring plan from day one, alongside technical performance. A model performing exactly as validated while being dismissed ninety percent of the time is delivering nothing, and only one of those two facts appears on a performance dashboard.

Who buys it

Reference content: CMIO, chief medical officer, library and knowledge services, pharmacy leadership. Alerting: clinical informatics and the specialty owning the rule. Predictive models: clinical informatics, analytics or data science leadership, quality and safety, and the AI governance body where one exists.

Who provides it

Structured profiles are in the clinical decision support vendor directory. Note that the directory includes electronic health record vendors in this category deliberately, because for many organizations the first predictive models in use arrived that way rather than as a separate purchase.

AIMedicineNow explains the clinical review behind this category in how hospitals evaluate clinical AI vendors. This page stays focused on the institutional buying decision.

Where this goes next

More in Solutions

  • Ambient Clinical Documentation Tools that listen to the encounter and draft the note. The most actively evaluated clinical AI category in United States health systems, and the one with the clearest buying chain.
  • Healthcare AI Governance and Monitoring A category that is still mostly a set of internal practices rather than a set of products. That distinction matters when you are deciding what to buy.
  • Radiology and Imaging AI The oldest and largest clinical AI category by product count. Also the one where the deciding constraint is almost never the algorithm.